616 related articles for article (PubMed ID: 22127667)
1. Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathways.
Hama M; Kirino Y; Takeno M; Takase K; Miyazaki T; Yoshimi R; Ueda A; Itoh-Nakadai A; Muto A; Igarashi K; Ishigatsubo Y
Arthritis Rheum; 2012 May; 64(5):1518-28. PubMed ID: 22127667
[TBL] [Abstract][Full Text] [Related]
2. Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis.
Sakai E; Shimada-Sugawara M; Nishishita K; Fukuma Y; Naito M; Okamoto K; Nakayama K; Tsukuba T
J Cell Biochem; 2012 Feb; 113(2):486-98. PubMed ID: 21928347
[TBL] [Abstract][Full Text] [Related]
3. TLR4 activation alters labile heme levels to regulate BACH1 and heme oxygenase-1 expression in macrophages.
Sudan K; Vijayan V; Madyaningrana K; Gueler F; Igarashi K; Foresti R; Motterlini R; Immenschuh S
Free Radic Biol Med; 2019 Jun; 137():131-142. PubMed ID: 31026585
[TBL] [Abstract][Full Text] [Related]
4. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation.
Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y
J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption.
Zwerina J; Tzima S; Hayer S; Redlich K; Hoffmann O; Hanslik-Schnabel B; Smolen JS; Kollias G; Schett G
FASEB J; 2005 Dec; 19(14):2011-3. PubMed ID: 16234431
[TBL] [Abstract][Full Text] [Related]
6. RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice.
Kanzaki H; Shinohara F; Itohiya K; Yamaguchi Y; Katsumata Y; Matsuzawa M; Fukaya S; Miyamoto Y; Wada S; Nakamura Y
FASEB J; 2017 Feb; 31(2):781-792. PubMed ID: 27836987
[TBL] [Abstract][Full Text] [Related]
7. Cell-type-specific downregulation of heme oxygenase-1 by lipopolysaccharide via Bach1 in primary human mononuclear cells.
Dorresteijn MJ; Paine A; Zilian E; Fenten MG; Frenzel E; Janciauskiene S; Figueiredo C; Eiz-Vesper B; Blasczyk R; Dekker D; Pennings B; Scharstuhl A; Smits P; Larmann J; Theilmeier G; van der Hoeven JG; Wagener FA; Pickkers P; Immenschuh S
Free Radic Biol Med; 2015 Jan; 78():224-32. PubMed ID: 25463280
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated heme oxygenase-1
Kishimoto D; Kirino Y; Tamura M; Takeno M; Kunishita Y; Takase-Minegishi K; Nakano H; Kato I; Nagahama K; Yoshimi R; Igarashi K; Aoki I; Nakajima H
Arthritis Res Ther; 2018 Apr; 20(1):64. PubMed ID: 29636091
[TBL] [Abstract][Full Text] [Related]
9. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
[TBL] [Abstract][Full Text] [Related]
10. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
11. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
[TBL] [Abstract][Full Text] [Related]
13. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
14. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
Gong W; Dou H; Liu X; Sun L; Hou Y
Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
[TBL] [Abstract][Full Text] [Related]
16. Bach1 deficiency reduces severity of osteoarthritis through upregulation of heme oxygenase-1.
Takada T; Miyaki S; Ishitobi H; Hirai Y; Nakasa T; Igarashi K; Lotz MK; Ochi M
Arthritis Res Ther; 2015 Oct; 17():285. PubMed ID: 26458773
[TBL] [Abstract][Full Text] [Related]
17. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
18. IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo.
Yoshimatsu M; Kitaura H; Fujimura Y; Eguchi T; Kohara H; Morita Y; Yoshida N
Bone; 2009 Nov; 45(5):1010-6. PubMed ID: 19651258
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis.
Nakasa T; Shibuya H; Nagata Y; Niimoto T; Ochi M
Arthritis Rheum; 2011 Jun; 63(6):1582-90. PubMed ID: 21425254
[TBL] [Abstract][Full Text] [Related]
20. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.
De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V
J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
